Literature DB >> 24045429

Epidemiologic study of residential proximity to transmission lines and childhood cancer in California: description of design, epidemiologic methods and study population.

Leeka Kheifets1, Catherine M Crespi2, Chris Hooper3, Sona Oksuzyan1, Myles Cockburn4, Thomas Ly4, Gabor Mezei5.   

Abstract

We conducted a large epidemiologic case-control study in California to examine the association between childhood cancer risk and distance from the home address at birth to the nearest high-voltage overhead transmission line as a replication of the study of Draper et al. in the United Kingdom. We present a detailed description of the study design, methods of case ascertainment, control selection, exposure assessment and data analysis plan. A total of 5788 childhood leukemia cases and 3308 childhood central nervous system cancer cases (included for comparison) and matched controls were available for analysis. Birth and diagnosis addresses of cases and birth addresses of controls were geocoded. Distance from the home to nearby overhead transmission lines was ascertained on the basis of the electric power companies' geographic information system (GIS) databases, additional Google Earth aerial evaluation and site visits to selected residences. We evaluated distances to power lines up to 2000 m and included consideration of lower voltages (60-69 kV). Distance measures based on GIS and Google Earth evaluation showed close agreement (Pearson correlation >0.99). Our three-tiered approach to exposure assessment allowed us to achieve high specificity, which is crucial for studies of rare diseases with low exposure prevalence.

Entities:  

Mesh:

Year:  2013        PMID: 24045429      PMCID: PMC4617228          DOI: 10.1038/jes.2013.48

Source DB:  PubMed          Journal:  J Expo Sci Environ Epidemiol        ISSN: 1559-0631            Impact factor:   5.563


  20 in total

1.  Factors that explain the power line configuration wiring code-childhood leukemia association: what would they look like?

Authors:  B Langholz
Journal:  Bioelectromagnetics       Date:  2001       Impact factor: 2.010

Review 2.  The management of neoplastic disorders of haematopoiesis in children with Down's syndrome.

Authors:  B Lange
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

Review 3.  Selection bias and its implications for case-control studies: a case study of magnetic field exposure and childhood leukaemia.

Authors:  Gabor Mezei; Leeka Kheifets
Journal:  Int J Epidemiol       Date:  2005-11-22       Impact factor: 7.196

4.  Childhood cancer and power lines: results depend on chosen control group.

Authors:  Leeka Kheifets; Maria Feychting; Joachim Schüz
Journal:  BMJ       Date:  2005-09-17

5.  Methods used to estimate residential exposure to 50 Hz magnetic fields from overhead power lines in an epidemiological study in France.

Authors:  Jérôme Bessou; François Deschamps; Lionel Figueroa; Damien Cougnaud
Journal:  J Radiol Prot       Date:  2013-03-13       Impact factor: 1.394

Review 6.  A pooled analysis of magnetic fields, wire codes, and childhood leukemia. Childhood Leukemia-EMF Study Group.

Authors:  S Greenland; A R Sheppard; W T Kaune; C Poole; M A Kelsh
Journal:  Epidemiology       Date:  2000-11       Impact factor: 4.822

7.  Childhood cancer and magnetic fields from high-voltage power lines in England and Wales: a case-control study.

Authors:  M E Kroll; J Swanson; T J Vincent; G J Draper
Journal:  Br J Cancer       Date:  2010-09-28       Impact factor: 7.640

Review 8.  Viral contacts confound studies of childhood leukemia and high-voltage transmission lines.

Authors:  J D Sahl
Journal:  Cancer Causes Control       Date:  1994-05       Impact factor: 2.506

9.  Birth weight and other perinatal factors and childhood CNS tumors: a case-control study in California.

Authors:  S Oksuzyan; C M Crespi; M Cockburn; G Mezei; L Kheifets
Journal:  Cancer Epidemiol       Date:  2013-04-03       Impact factor: 2.984

10.  Extremely low-frequency magnetic fields and survival from childhood acute lymphoblastic leukemia: an international follow-up study.

Authors:  J Schüz; K Grell; S Kinsey; M S Linet; M P Link; G Mezei; B H Pollock; E Roman; Y Zhang; M L McBride; C Johansen; C Spix; J Hagihara; A M Saito; J Simpson; L L Robison; J D Dockerty; M Feychting; L Kheifets; K Frederiksen
Journal:  Blood Cancer J       Date:  2012-12-21       Impact factor: 11.037

View more
  6 in total

1.  Estimating magnetic fields of homes near transmission lines in the California Power Line Study.

Authors:  Ximena P Vergara; Robert Kavet; Catherine M Crespi; Chris Hooper; J Michael Silva; Leeka Kheifets
Journal:  Environ Res       Date:  2015-05-22       Impact factor: 6.498

2.  Childhood leukemia risk in the California Power Line Study: Magnetic fields versus distance from power lines.

Authors:  Catherine M Crespi; John Swanson; Ximena P Vergara; Leeka Kheifets
Journal:  Environ Res       Date:  2019-01-11       Impact factor: 6.498

3.  The sensitivity of reported effects of EMF on childhood leukemia to uncontrolled confounding by residential mobility: a hybrid simulation study and an empirical analysis using CAPS data.

Authors:  Aryana T Amoon; Onyebuchi A Arah; Leeka Kheifets
Journal:  Cancer Causes Control       Date:  2019-05-29       Impact factor: 2.506

4.  Residential magnetic fields exposure and childhood leukemia: a population-based case-control study in California.

Authors:  Leeka Kheifets; Catherine M Crespi; Chris Hooper; Myles Cockburn; Aryana T Amoon; Ximena P Vergara
Journal:  Cancer Causes Control       Date:  2017-09-12       Impact factor: 2.506

Review 5.  Magnetic Fields and Cancer: Epidemiology, Cellular Biology, and Theranostics.

Authors:  Massimo E Maffei
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

6.  Childhood leukaemia and distance from power lines in California: a population-based case-control study.

Authors:  Catherine M Crespi; Ximena P Vergara; Chris Hooper; Sona Oksuzyan; Sheng Wu; Myles Cockburn; Leeka Kheifets
Journal:  Br J Cancer       Date:  2016-05-24       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.